Literature DB >> 18396191

Clinical implications of insight assessment in obsessive-compulsive disorder.

Pino Alonso1, José M Menchón, Cinto Segalàs, Nuria Jaurrieta, Susana Jiménez-Murcia, Narcís Cardoner, Javier Labad, Eva Real, Alberto Pertusa, Julio Vallejo.   

Abstract

Poor insight has been reported in 15% to 36% of patients with obsessive-compulsive disorder (OCD), but little is known about its clinical correlations. This study examines insight among patients with OCD using a standardized instrument, the Brown Assessment of Beliefs Scale, and analyzes its relationship with clinical factors. Insight was assessed in 132 patients with OCD, before and after pharmacologic treatment, using the Brown Assessment of Beliefs Scale. Differences between patients with good and poor insight on sociodemographic variables, OCD severity, comorbidity, and treatment response were studied. Stability of insight after pharmacologic treatment was also examined. Thirty-nine patients (29.5%) exhibited poor insight. They showed more depressive symptoms (P = .001) and personality disorders (P = .001), especially the schizotypal form, than did good insight subjects, but there were no significant differences in treatment response. Insight significantly improves after treatment (P < .001). Our results suggest that insight in OCD varies widely and constitutes a dynamic phenomenon that can improve after treatment and is influenced by clinical conditions such as affective status or personality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18396191     DOI: 10.1016/j.comppsych.2007.09.005

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  17 in total

1.  Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ashley S Hart; William Menard; Jane L Eisen
Journal:  J Nerv Ment Dis       Date:  2013-07       Impact factor: 2.254

2.  A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder.

Authors:  Katharine A Phillips; Anthony Pinto; Ashley S Hart; Meredith E Coles; Jane L Eisen; William Menard; Steven A Rasmussen
Journal:  J Psychiatr Res       Date:  2012-07-21       Impact factor: 4.791

3.  Symmetry Concerns as a Symptom of Body Dysmorphic Disorder.

Authors:  Ashley S Hart; Katharine A Phillips
Journal:  J Obsessive Compuls Relat Disord       Date:  2013-07-01       Impact factor: 1.677

4.  Dimensional correlates of poor insight in obsessive-compulsive disorder.

Authors:  Ewgeni Jakubovski; Christopher Pittenger; Albina Rodrigues Torres; Leonardo Franklin Fontenelle; Maria Conceicao do Rosario; Ygor Arzeno Ferrão; Maria Alice de Mathis; Euripedes Constantino Miguel; Michael H Bloch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-27       Impact factor: 5.067

5.  Delusional misidentification syndromes in obsessive-compulsive disorder.

Authors:  Isabela A Melca; Clarissa L Rodrigues; Maria A Serra-Pinheiro; Christos Pantelis; Dennis Velakoulis; Mauro V Mendlowicz; Leonardo F Fontenelle
Journal:  Psychiatr Q       Date:  2013-06

6.  Phenomenology of OCD: lessons from a large multicenter study and implications for ICD-11.

Authors:  Roseli G Shavitt; Maria Alice de Mathis; Fábio Oki; Ygor A Ferrao; Leonardo F Fontenelle; Albina R Torres; Juliana B Diniz; Daniel L C Costa; Maria Conceição do Rosário; Marcelo Q Hoexter; Euripedes C Miguel; H Blair Simpson
Journal:  J Psychiatr Res       Date:  2014-06-26       Impact factor: 4.791

7.  Correlates of insight among youth with obsessive-compulsive disorder.

Authors:  Adam B Lewin; R Lindsey Bergman; Tara S Peris; Susanna Chang; James T McCracken; John Piacentini
Journal:  J Child Psychol Psychiatry       Date:  2009-12-17       Impact factor: 8.982

8.  Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report.

Authors:  Michele Fornaro; Matteo Martino
Journal:  Ann Gen Psychiatry       Date:  2010-12-10       Impact factor: 3.455

9.  Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report.

Authors:  Michele Fornaro; Filippo Gabrielli; Chiara Mattei; Valentina Vinciguerra; Pantaleo Fornaro
Journal:  Ann Gen Psychiatry       Date:  2008-12-23       Impact factor: 3.455

10.  A cross-sectional study of insight and family accommodation in pediatric obsessive-compulsive disorder.

Authors:  Rajshekhar Bipeta; Srinivasa Srr Yerramilli; Srilakshmi Pingali; Ashok Reddy Karredla; Mohammad Osman Ali
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2013-06-20       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.